Barbier M, Chaspoul P, Dabin J C, Durupt D, Franco L, Naudin D
Sem Hop. 1979;55(35-36):1618-22.
A therapeutic study was conducted by practitioners working in a group practice, to evaluate the activity of tiapride in treating headaches, over a period of 1 year. The results were satisfactory in 60.6% of cases, especially in patients with headaches of psychogenic or digestive origin. The dosage was 150 to 200 mg orally, and the product was well tolerated apart from somnolence which was noted in about 1 case out of 4.
一个团队诊所的从业者进行了一项治疗研究，以评估硫必利治疗头痛的效果，为期1年。60.6%的病例结果令人满意，尤其是对心因性或消化源性头痛患者。剂量为口服150至200毫克，除了约四分之一的病例出现嗜睡外，该产品耐受性良好。
